Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NWBO | US
-0.02
-7.15%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.28
0.30
0.30
0.27
Northwest Biotherapeutics Inc. a biotechnology company develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product DCVax-L which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda Maryland.
View LessStrong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
57.2%1 month
53.0%3 months
50.9%6 months
52.0%-
-
-
-
-
-11.91
262.66
-
-60.47M
346.53M
346.53M
-
-3.42K
-
153.70
-
13.54
15.09
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.06
Range1M
0.09
Range3M
0.15
Rel. volume
0.95
Price X volume
312.87K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc | ANIK | Biotechnology | 24.44 | 361.63M | -2.47% | n/a | 13.35% |
| Fate Therapeutics Inc | FATE | Biotechnology | 3.15 | 358.72M | -2.48% | n/a | 25.33% |
| INZY | INZY | Biotechnology | 5.28 | 354.28M | -4.69% | n/a | 49.47% |
| Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 10.52 | 347.80M | -5.40% | n/a | 6.58% |
| Nautilus Biotechnology Inc. | NAUT | Biotechnology | 2.77 | 347.39M | -6.10% | n/a | 13.86% |
| Bright Minds Biosciences Inc. Common Stock | DRUG | Biotechnology | 48.02 | 338.04M | 1.72% | n/a | 0.23% |
| Monte Rosa Therapeutics Inc | GLUE | Biotechnology | 5.45 | 334.48M | -1.27% | n/a | 19.74% |
| XOMA Corporation | XOMA | Biotechnology | 28.46 | 333.11M | -3.20% | n/a | 121.93% |
| ITOS | ITOS | Biotechnology | 9.1 | 332.35M | -3.50% | n/a | 0.83% |
| ProQR Therapeutics N.V | PRQR | Biotechnology | 4.05 | 330.80M | -6.47% | n/a | 53.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.97 | 352.77M | -6.27% | n/a | 286.96% |
| Marine Products Corporation | MPX | Recreational Vehicles | 9.38 | 325.65M | -4.19% | 13.23 | 0.00% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 16.86 | 280.00M | -3.55% | 34.27 | 26.82% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 23.4 | 261.09M | -1.39% | 15.61 | -621.78% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.53 | 236.68M | -1.96% | 9.09 | 39.79% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.55 | 145.88M | -0.79% | n/a | 58.43% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.87 | 94.40M | 1.83% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 14.22 | 89.04M | -1.80% | 14.48 | 7.10% |
| Urban One Inc | UONEK | Broadcasting - Radio | 1.01 | 53.54M | -3.35% | n/a | 268.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.91 | - | Cheaper |
| Ent. to Revenue | 262.66 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 50.92 | - | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 346.53M | - | Emerging |